
✓
Open
9 Nov 2020
✓
Close
11 Nov 2020
3
Allotment
—
✓
Listing
Fri, Nov 20, 2020
Price Band
₹1490 to ₹1500
Issue Size
4,31,96,968 shares (agg. up to ₹6,480 Cr)
Lot Size
10 Shares
Listing Date
Fri, Nov 20, 2020
Latest GMP
₹118
Est. Gain
7.87%
✦ AI Insight
GMP Trend
18-11-2020₹118Est. ₹1618+7.87%
11-11-2020₹20Est. ₹1520+1.33%
10-11-2020₹25Est. ₹1525+1.67%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.72x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Jun 2020 | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2018 |
|---|---|---|---|---|
| Assets | 4,691.27 | 4,086.04 | 3,523.55 | 2,929.47 |
| Total Income | 916.29 | 2,772.41 | 2,129.77 | 1,671.68 |
| Profit After Tax | 313.59 | 772.86 | 451.86 | 321.05 |
| EBITDA | 444.70 | 1,094.64 | 792.07 | 584.08 |
| NET Worth | 3,963.47 | 3,646.24 | 2,862.00 | 2,410.36 |
| Reserves and Surplus | 3,947.97 | 3,630.74 | 2,846.50 | 2,394.86 |
| Total Borrowing | 4.96 | 4.96 | 5.49 | 5.92 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Chandra Bhagat Pharma Ltd. | SME | ₹10.20 Cr | ₹51 | 51 | ₹51.75 | +1.47% | ₹47.00 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding incremental working capital requirements of our Company | 769.50 |
| 2 | Funding capital expenditure requirements of our Company | 168.00 |
| 3 | General corporate purposes | 286.47 |
About Gland Pharma IPO
Updated on Aug 5, 2026
Contact Details
Gland Pharma Ltd. AddressSy.No.143-148, 150 and 151Near Gandi Maisamma 'X' Roads, D.P.Pally, DundigalMedchal-Malkajgiri, Dist.HyderabadHyderabad, Telangana, 501401+91 40 3051 0999investors@glandpharma.comVisit Website